Feasibility of Immunotherapy of Relapsed Leukemia With Ex Vivo–Generated Cytotoxic T Lymphocytes Specific for Hematopoietic System-Restricted Minor Histocompatibility Antigens

作者: Tuna Mutis , Rob Verdijk , Ellen Schrama , Bennie Esendam , Anneke Brand

DOI: 10.1182/BLOOD.V93.7.2336

关键词:

摘要: Allogeneic bone marrow transplantation (BMT) is a common treatment of hematologic malignancies. Recurrence the underlying malignancy major cause failure. Donor-derived cytotoxic T lymphocytes (CTLs) specific for patients’ minor histocompatibility antigens (mHags) play an important role in both graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) reactivities. mHags HA-1 HA-2 induce HLA-A*0201-restricted CTLs vivo are exclusively expressed on hematopoietic cells, including leukemic cells precursors, but not fibroblasts, keratinocytes, or liver cells. The chemical nature known. We investigated feasibility ex generation mHag HA-1– HA-2–specific from unprimed and/or HA-2–negative healthy blood donors. synthetic peptide-pulsed dendritic (DCs) were used as antigen-presenting (APC) to stimulate autologous CD8+ vivo–generated efficiently lyse derived acute myeloid leukemia (AML) lymphoid (ALL) patients. No lytic reactivity was detected against nonhematopoietic Sufficient numbers can be obtained adoptive immunotherapy purposes. In conclusion, we present feasible, novel therapy relapsed after BMT with low risk GVHD.

参考文章(27)
MM Horowitz, RP Gale, PM Sondel, JM Goldman, J Kersey, HJ Kolb, AA Rimm, O Ringden, C Rozman, B Speck, Graft-versus-leukemia reactions after bone marrow transplantation Blood. ,vol. 75, pp. 555- 562 ,(1990) , 10.1182/BLOOD.V75.3.555.555
E. G. Engleman, Anita Mehta-Damani, S. Markowicz, Generation of antigen-specific CD8+ CTLs from naive precursors. Journal of Immunology. ,vol. 153, pp. 996- 1003 ,(1994)
D Niederwieser, A Grassegger, J Aubock, M Herold, D Nachbaur, A Rosenmayr, A Gachter, W Nussbaumer, S Gaggl, M Ritter, Correlation of minor histocompatibility antigen-specific cytotoxic T lymphocytes with graft-versus-host disease status and analyses of tissue distribution of their target antigens Blood. ,vol. 81, pp. 2200- 2208 ,(1993) , 10.1182/BLOOD.V81.8.2200.2200
Ettore Appella, Yutaka Kawakami, Scott Southwood, Kazuyasu Sakaguchi, Alessandro Sette, Esteban Celis, Van Tsai, John Sidney, Identification of subdominant CTL epitopes of the GP100 melanoma-associated tumor antigen by primary in vitro immunization with peptide-pulsed dendritic cells. Journal of Immunology. ,vol. 158, pp. 1796- 1802 ,(1997)
Jacques Banchereau, Ralph M. Steinman, Dendritic cells and the control of immunity Nature. ,vol. 392, pp. 245- 252 ,(1998) , 10.1038/32588
HJ Kolb, A Schattenberg, JM Goldman, B Hertenstein, N Jacobsen, W Arcese, P Ljungman, A Ferrant, L Verdonck, D Niederwieser, Graft-Versus-Leukemia Effect of Donor Lymphocyte Transfusions in Marrow Grafted Patients Blood. ,vol. 86, pp. 2041- 2050 ,(1995) , 10.1182/BLOOD.V86.5.2041.BLOODJOURNAL8652041
L M Faber, J van der Hoeven, E Goulmy, A L Hooftman-den Otter, S A van Luxemburg-Heijs, R Willemze, J H Falkenburg, Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes. Journal of Clinical Investigation. ,vol. 96, pp. 877- 883 ,(1995) , 10.1172/JCI118134
Ellen van Lochem, Maarten van der Keur, A Mieke Mommaas, Gijsbert C de Gast, Els Goulmy, Functional expression of minor Histocompatibility antigens on human peripheral blood dendritic cells and epidermal Langerhans cells. Transplant Immunology. ,vol. 4, pp. 151- 157 ,(1996) , 10.1016/S0966-3274(96)80009-8